Research study

#Funding #Molecular Genomics #Proteomics #Research study #Singapore #SomaLogic

Proteomics grant programme open to Singapore researchers

Proteomics company SomaLogic is sponsoring the Genomax Research Grant Award for researchers in Singapore, the company’s first grant in the APAC region. The winners of the award will receive proteomic data from SomaLogic’s 7,000-plex assay, which will be run at Singapore-based Molecular Genomics. The… Read More

#News

#Antivirals #Monkeypox #Research study

Can a smallpox antiviral be used to treat monkeypox?

A new study has found that the antiviral tecovirimat (TPOXX) appears to be safe and effective for the treatment of monkeypox symptoms and skin lesions. This University of California Davis Health (UC Davis Health) study is one of the earliest studies to assess and report the outcomes of treating patients… Read More

#News #Trending News

#Clinical trials #Research study

This week in drug discovery (21-25 March) 

News round-up by DDW’s Megan Thomas for 14-18 March, 2022  New breakthroughs, results, clinical trials and research exemplify the constant and forward-moving trajectory of the drug discovery and development industry in this week’s news round up.  1. Atrogi gets go-ahead to begin Phase I study… Read More

#News

#Approvals #Collaboration #Drug discovery #Public health #Research study

This week in drug discovery (14-18 February) 

News round-up by DDW’s Megan Thomas for 14-18 February, 2022  This week, DDW rounds up updates, approvals, research and trials which will enable scientists to make life-saving developments in the drug discovery industry.  1. Trial launched of HIV vaccine antigens delivered through mRNA technology… Read More

#News

#Covid-19 #Public health #Research study

SARS-CoV-2 human challenge studies are safe in healthy young adults 

Open Orphan has released the results from its Covid-19 characterisation study, which was a partnership between hVIVO, Imperial College London, the Vaccine Taskforce and Department of Health and Social Care (DHSC), and the Royal Free London NHS Foundation Trust. The results from this study show that a SARS-CoV-2 human… Read More

#News

#Cytokines #In vitro #In vivo #Research study #Whitepaper

White Paper: A new way to study cytokine release syndrome

An in vivo CRS Evaluation Study in humanised mouse models can deliver fast, reproducible, and translatable data about drug safety in just two weeks. A humanised mouse platform offers the unique ability to preclinically analyse a fully systemic response that involves human immune cells and surrounding tissues. Furthermore, the platform… Read More

#News #Trending News

#Collaboration #Research study

This week in drug discovery (10-14 January) 

News round-up by DDW’s Megan Thomas for 10-14 January, 2022  Studies, approvals and research are at the heart of drug discovery, which has been exemplified in this week’s drug discovery news. Megan Thomas has rounded up her top five stories of the week.   Vaccine-like mRNA injection can be… Read More

#News #Trending News

#HIV #Research study

Can tomato concentrate reduce inflammation associated with HIV? 

New UCLA-led research in mice suggests that adding a certain type of tomato concentrate to the diet can reduce the intestinal inflammation that is associated with HIV. Left untreated, intestinal inflammation can accelerate arterial disease, which in turn can lead to heart attack and stroke. The study is published… Read More

#News

#Crohn's disease #Research study

Study links gut fungi to inflammation in Crohn’s disease patients 

Results of a new study by researchers at Case Western Reserve University represent a step toward improving understanding of Crohn’s disease and the factors that cause its intestinal inflammation.  About Crohn’s disease  Crohn’s disease is a type of inflammatory bowel disease that can lead… Read More

#News

#Covid-19 #Research study #T-Cells

How is Japan keeping Covid-19 cases so low? 

Research by the Riken Institute in Tokyo, published in the British journal Communications Biology, offers an explanation for Japan’s success in tackling the Covid-19 pandemic when compared with other countries. The research is a piece of the puzzle of why there remains relatively low rates of death and serious… Read More

#Covid-19 #News #Trending News

#Covid variants #Covid-19 #Omicron #Research study

Qatari research proves natural immunity theory for Covid-19 

New research from Qatar, published in the New England Journal of Medicine, has found that the natural immunity from prior infection of Covid-19 has a 92% efficacy against reinfection of the Beta variant, and a 98% efficacy against reinfection of the Alpha variant.   The study … Read More

#Covid-19 #News

#Autoimmune disease #Biology #Drug development #Drug discovery #Research study #Therapeutics

Human-on-a-Chip approach validated to model rare autoimmune disease

A new peer-reviewed article demonstrated that Hesperos’ Human-on-a-Chip (HoaC) cell-based neuromuscular junction (NMJ) platform system can mimic the disease phenotypes of myasthenia gravis (MG). The manuscript, titled “A Functional Human-on-a-Chip Autoimmune Disease Model of Myasthenia Gravis for Development of Therapeutics,” was published in Frontiers in Cell and Developmental Biology. Read More

#News

#Data #Drug development #Drug discovery #Genomics #Research study #Tuberculosis

Largest ever global TB study identifies genetic causes of drug resistance 

The Comprehensive Resistance Prediction for Tuberculosis International Consortium (CRyPTIC) research project has reportedly collected the largest ever global dataset of clinical M. tuberculosis samples from across the world consisting of 15,211 samples from 27 countries on five continents.  Using a new quantitative test for drug resistance and… Read More

#News #Trending News